September 2014
QPS360 Newsletter - 9th Edition
QPS Launches New Responsive Website!
Neuronal Plasticity
An Inducible Murine Model of Tau Phosphorylation
α-Synuclein A53T Mice Present with Progressive Motor Decline
QPS/THI Summer Webinar Series - Quantitative Whole-Body Autoradiography (QWBA) in Drug Discovery and Development
QPS/THI Summer Webinar Series - Predicting Hepatoxic Potential of NCE's in Patients
QPS/THI Summer Webinar Series - Interpreting the Enzyme Induction EMA and FDA Guidance for Industry
QPS Hepatic Biosciences scientists co-author Article on the interpretation of the pre-clinical liver effects seen with a NCE
New Drug Assays added to the QPS Global Assay Database
Translational Medicine
Development and Validation of Cell-Based Neutralizing Anti-Adalimumab Antibody Detection Methods for Adalimumab Biosimilar Program
New Biomarker Assays at QPS Are Paving the Way for Personalized Medicine
Early Stage Clinical
Doug Kalman, Director of QPS MRA's Nutrition/Endocrinology Department publishes Article on the Amino Acid Composition of Concentrated Protein Powders
Paul Lehman, QPS' Vice President and Head of Dermal and Transdermal Research publishes Article on Assessing the Relative Bioavailability of Topical Clobetasol Propionate Products
Late Stage Clinical
QPS Respiratory & Allergy News
Fresh from the Pipeline
Fresh from the pipeline
The Latest Original New FDA and EMA Drug Approvals  more
Posters - You Talk
Posters You Talk
CAA in Mutant AD Mice - A Comparative Study to Human AD Cases  more
QPS Tube
QPS Tube
QPS/THI Summer Webinar Series  more
See You @
See You
19th North American Regional
ISSX Meeting and 29th JSSX Annual Meeting
October 19 - 23, 2014
San Francisco, CA, USA